News & Updates

The novel third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) aumolertinib appears to be effective in the treatment of patients with EGFR T790M-positive advanced nonsmall cell lung carcinoma (NSCLC) following progression on first- and second-generation EGFR TKI therapy, according to data from the phase II APOLLO Registrational Trial.

Most patients with traumatic brain injury receive delayed prophylaxis, with no association seen between incidence of venous thromboembolism (VTE) and prophylaxis regimen, suggests a study. However, a significant difference is observed in VTE incidence stratified by time to prophylaxis.

Ritlecitinib and brepocitinib, both Janus kinase (JAK) inhibitors, show promising efficacy for the treatment of alopecia areata (AA), a new trial has found.

Short-term treatment with zolpidem or zopiclone in older patients with Alzheimer’s disease and insomnia appears beneficial, even though safety and tolerance issues have yet to be personalized in healthcare settings and further investigated in subsequent trials, according to a study.

Administering acupuncture with a zap to patients with severe chronic constipation produces better outcomes than transcutaneous electrical stimulation, increasing the frequency of complete spontaneous bowel movements and improving quality of life, as shown in a study.